HIV/AIDS Clinical Trials

Showing 1621-1640 of 1,802 trials

Effect of Male Circumcision on HIV Incidence (ANRS 1265)

NCT00122525

Observational studies suggest that male circumcision may provide protection against HIV-1 infection. A randomized, controlled, intervention trial was conducted in a general population of South Africa to test this hypothesis.

HIV InfectionsHerpes GenitalisVenereal Diseases

French National Agency for Research on AIDS and Viral Hepatitis3,274 participantsStarted Jul 2002

Orange Farm, Johannesburg, South Africa

UNKNOWNPhase 1

Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV)

NCT00858923

Tulane University Health Sciences Center/Louisiana Community AIDS Research Center Program, New Orleans, LA is seeking patients for an HIV study. The purpose of the study is to test the safety and effectiveness of an experimental ultra-violet light device designed to reduce virus in your blood.

HIVHIV Infections

Energex Systems, Inc.10 participantsStarted Jul 2008

New Orleans, Louisiana, United States

COMPLETEDNA

A Cluster-Randomized Intervention Trial to Improve Quality of Life for HIV-Infected Individuals in Anhui, China

NCT00479141

The HIV epidemic in China has reached a phase of exponential growth; the number of new infections has been steadily increasing over the past decade. The purpose of this study is to evaluate the effectiveness of a Combined Individual- and Community-Based Behavioral Intervention to Improve Quality of Life for HIV-Positive Villagers and decrease HIV related stigma in Rural China.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)3,199 participantsStarted Mar 2006

Beijing, China

Effect of Male Circumcision on HIV Incidence (ANRS 1265)

Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV)

A Cluster-Randomized Intervention Trial to Improve Quality of Life for HIV-Infected Individuals in Anhui, China

Related Searches

Stress-Reducing Interventions in HIV+ Patients: Pilot

The Intervention With Microfinance for AIDS and Gender Equity (IMAGE) Study

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects

Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage

Pharmacokinetic Study Of EPZICOM Tablet

Efficacy of Influenza Vaccine in HIV Infected Adults

Nursing Intervention for HIV Regime Adherence Among People With Serious Mental Illness (SMI)

Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients

Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis

Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults

Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir

L-Carnitine to Treat Fatigue in AIDS Patients

The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients